Switching From Dual to Monotherapy for Gonorrhea is Associated With a Halving of Gonococcal Resistance to Azithromycin—A Modelling Study of MSM in Belgium
Switching from dual to monotherapy was associated with a halving of the prevalence of AR-NG. These results provide further evidence to favor mono- over dual therapy for the treatment of gonorrhea.
Authors
- Niel Hens (ORCID: https://orcid.org/0000-0003-1881-0637)
- Achilleas Tsoumanis (ORCID: https://orcid.org/0000-0001-7565-1359)
- Chris Kenyon (ORCID: https://orcid.org/0000-0002-2557-8998)
- Christophe Van Dijck (ORCID: https://orcid.org/0000-0001-8010-1351)
Institutions
- University of Antwerp (BE)
- University of Cape Town (ZA)
- Infectious Diseases Institute (UG)
- Instituut voor Tropische Geneeskunde (BE)
- Hasselt University (BE)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1093/ofid/ofaf320
- Citations
- 2
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.37
Funders
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering